A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Author | :
|
---|---|
Abstract | :
To test the hypothesis that chronic treatment of early-stage Huntington disease (HD) with high-dose coenzyme Q10 (CoQ) will slow the progressive functional decline of HD. |
Year of Publication | :
2017
|
Journal | :
Neurology
|
Volume | :
88
|
Issue | :
2
|
Number of Pages | :
152-159
|
Date Published | :
2017
|
ISSN Number | :
0028-3878
|
URL | :
http://www.neurology.org/cgi/pmidlookup?view=long&pmid=27913695
|
DOI | :
10.1212/WNL.0000000000003478
|
Short Title | :
Neurology
|
Download citation |